Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ARIQUELI: Lithium vs Aripiprazole for Quetiapine-Refractory Bipolar I
NCT01710163Phase 4Unknown
- Sponsor
- Universidade de São Paulo
- Start
- Jun 2012
- Primary completion
- Jun 2013
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 4 trial of lithium, aripiprazole in bipolar I disorder, sponsored by Universidade de São Paulo. Status: unknown.
02
Drugs
lithiumaripiprazole
03
Conditions
bipolar I disorder
Beyond the preview
Go deeper on NCT01710163.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01710163.